Basic Information
Immunomedics is a clinical-stage biopharmaceutical company dedicated to developing monoclonal antibody-based targeted therapies for serious diseases such as cancer. The corporate goal of Immunomedics is to become a fully integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.
Immunomedics, Inc.
NewJersey,United States of America
101~500 people
July 01, 1982
contact@immunomedics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios